Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
In: BMC Cancer, Jg. 21 (2021), Heft 1, S. 1-9
Online
academicJournal
Zugriff:
Abstract Background Treatment for radioiodine refractory differentiated thyroid carcinoma (RR-DTC) is challenging. The purpose of this study was to assess the efficacy and safety of ultrasound-guided implantation of radioactive 125I-seed in radioiodine refractory differentiated thyroid carcinoma. Methods Thirty-six cervical metastatic lymph nodes (CMLNs) diagnosed with RR-DTC from 18 patients were enrolled in this retrospective study. US and contrast-enhanced ultrasound (CEUS) examinations were performed before implantation. Follow-up comprised US, CEUS, thyroglobulin (Tg) level and routine hematology at 1–3, 6, 9 and 12 months and every 6 months thereafter. The volumes of the nodules were compared before implantation and at each follow-up point. The volume reduction rate (VRR) of nodules was also recorded. Results The median volume of the nodules was 523 mm3 (148, 2010mm3) initially, which decreased significantly to 53mm3 (0, 286mm3) (P
Titel: |
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
|
---|---|
Autor/in / Beteiligte Person: | Chen, Wei ; Yu kun Luo ; Zhang, Ying ; Song, Qing ; Tang, Jie |
Link: | |
Zeitschrift: | BMC Cancer, Jg. 21 (2021), Heft 1, S. 1-9 |
Veröffentlichung: | BMC, 2021 |
Medientyp: | academicJournal |
ISSN: | 1471-2407 (print) |
DOI: | 10.1186/s12885-021-08500-5 |
Schlagwort: |
|
Sonstiges: |
|